Interactive Association Between CYP2C9 rs2860905 Polymorphism and Atrial Fibrillation on Ischemic Stroke in Taiwan

Jui-Wen Peng1, Oswald Ndi Nfor2, Chien-Chang Ho3,4

  • 1Institute of Medicine, Chung Shan Medical University, Taichung, 40201, Taiwan.

Insights

The GG genotype of the CYP2C9 rs2860905 variant increases ischemic stroke risk in Taiwanese adults, especially when combined with atrial fibrillation. This genetic factor is crucial for understanding stroke in Taiwan.

Area of Science:

  • Cardiovascular Genetics
  • Neurology
  • Pharmacogenomics

Background:

  • Ischemic stroke is a leading cause of disability, with atrial fibrillation as a significant risk factor.
  • Limited evidence exists on the interplay between atrial fibrillation, genetic variants, and ischemic stroke risk.

Purpose of the Study:

  • To investigate the association between the CYP2C9 rs2860905 variant, atrial fibrillation, and ischemic stroke risk in the Taiwan Biobank population.
  • To assess the role of genetic factors in ischemic stroke among Taiwanese adults.

Main Methods:

  • Logistic regression analysis was employed to analyze data from 17,726 participants in the Taiwan Biobank.
  • Odds ratios (OR) and 95% confidence intervals (CI) were calculated to determine the risk associated with atrial fibrillation and the rs2860905 variant.
  • Genotype-stratified analysis was performed to examine gene-environment interactions.

Main Results:

  • Atrial fibrillation showed a significant positive association with ischemic stroke (OR=3.70; 95% CI, 2.21-6.20).
  • The rs2860905 variant itself was not directly associated with ischemic stroke risk (OR=1.00; 95% CI, 0.82-1.22 for GA/AA vs. GG genotype).
  • Individuals with the GG genotype and atrial fibrillation had a substantially higher risk of ischemic stroke (OR=4.68; 95% CI, 2.70-8.09) compared to those without atrial fibrillation.

Conclusions:

  • The GG genotype of CYP2C9 rs2860905 significantly enhances ischemic stroke risk in Taiwanese adults, particularly when co-occurring with atrial fibrillation.
  • This genotype-specific risk warrants consideration in clinical and research settings for stroke prevention and management in Taiwan.
  • Understanding genetic predispositions like the CYP2C9 rs2860905 variant is vital for personalized medicine approaches to cardiovascular diseases.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.9K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
47
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
84